✦ LIBER ✦

Lenalidomide in relapsed/refractory B-CLL

Book ID: 120849066
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200615660-00046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5.5 Bendamustine and Lenalidomide in Rel

5.5 Bendamustine and Lenalidomide in Relapsed/Refractory CLL

✍ Chaitra S. Ujjani; Syed M. Karim; Trishna Goswami; Jenny Crawford; Edmund A. Geh 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 71 KB

Ofatumumab active in relapsed or refract

Ofatumumab active in relapsed or refractory B-cell CLL

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Lenalidomide offers hope in relapsed/ref

Lenalidomide offers hope in relapsed/refractory NHL

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Lenalidomide + rituximab for relapsed/re

Lenalidomide + rituximab for relapsed/refractory MCL

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Lenalidomide in patients with refractory

Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma

✍ Boris Böll; Peter Borchmann; Max S. Topp; Mathias Hänel; Katrin S. Reiners; Andr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Prolonged treatment with lenalidomide in

Prolonged treatment with lenalidomide in relapsed and refractory multiple myeloma

✍ Carlos Aguilar Franco; Luis Palomera; Jose Joaquín Ruiz Arredondo; Jesús Martín 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 499 KB